Did pharmacy board give Walgreens special treatment?
April 2nd 2014That’s the charge being made by a government watchdog group and a labor federation, which alleges that the Indiana Board of Pharmacy in 2011 approved Walgreens’ new pharmacy design with the help of the former board president who is employed by the drug chain.
The pharmacists’ role in transitions of care
April 2nd 2014Poor transitions in care cost the U.S. healthcare system $45 billion in 2011. Of the 1.5 million medication errors that harm patients each year, approximately 60% occur during transitions of care, according to Stephanie Kleyman, PharmD, who spoke about opportunities for pharmacists in transitions of care at the 2014 American Pharmacists Association annual meeting in Orlando.
Community pharmacies gain tools to help diabetes patients manage condition
March 28th 2014The American Pharmacists Association (APhA) Foundation, with its partner PrescribeWellness, is offering community pharmacies new tools to help diabetes patients manage their disease and health, according to an announcement from the APhA annual meeting in Orlando.
Specialty drug pricing pushing limits for hospital pharmacies
March 26th 2014Specialty drug pricing and generic drug pricing, especially around single-source generics during their exclusivity period, should be on the radar screens of hospital and managed care decision-makers, according to Catamaran’s 2013 Drug Trend data, which represents 25 million consumers.
Financial hardship in chronically ill may lead to medication underuse
March 26th 2014Chronically ill adults don’t have consistent access to food due to lack of financial stability were significantly more likely to report cost-related medication underuse, according to a new study published in The American Journal of Medicine. Cost-related medication underuse refers to taking less medication than prescribed, or not taking it at all because of financial concerns.
How to manage skin abscesses with MRSA
March 26th 2014More than a decade after the clinical battle began with community-acquired methicillin-resistant Staphylococcus aureus (MRSA), physicians are still trying to figure out how to diagnose, treat, and prevent this virulent form of staph infection, which is immune to many antibiotics.
Walgreens to close 76 drugstores in 2014
March 25th 2014Walgreens plans to close 76 of its drugstores nationwide between April and August 2014, which amounts to less than 2% of its stores, due to store density and non-optimal real estate, Walgreens President and CEO Greg Wasson, said during a conference call on March 25.
Find out how to boost hospital pharmacies’ profits
March 24th 2014There are many untapped opportunities for hospital pharmacies to boost their bottom lines, including expanding their services and capturing more reimbursements, according to Mary Baxter, RPh, vice president and national practice leader for Cardinal Health’s Innovation Delivery Solutions business.
How to avoid vaccine administration errors
March 24th 2014Influenza, zoster, hepatitis A, hepatitis B, and the diphtheria and tetanus toxoids and acellular pertussis adsorbed (DTaP) are among the most common vaccines involved in medication errors in the United States, according to a new report from the Institute for Safe Medication Practices (ISMP).
Feds probing alleged Walgreens HIPAA violations
March 21st 2014The U.S. Department of Health and Human Services’ (HHS) Office for Civil Rights has launched an investigation into alleged patient- privacy violations at Walgreens, following complaints that chain’s new pharmacy design is putting sensitive patient information at risk, according to the Wall Street Journal.
Perioperative statin therapy helps reduce VTE complications
March 18th 2014When used in conjunction with conventional blood clot prevention therapies, statins significantly reduced the risk for venous thromboembolic (VTE) events following total joint replacement (TJR) surgery, according to research presented recently at the 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
FDA approves exenatide ER pen for diabetes
March 17th 2014Bringing a new tool to the arsenal of medications to treat type 2 diabetes, FDA recently approved the only once-weekly injectable pen for adults with type 2 diabetes-exenatide extended-release for injectable suspension (AstraZeneca, Bydureon Pen).